These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38472366)

  • 21. Antiviral Candidates for Treating Hepatitis E Virus Infection.
    Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organotypic Brain Cultures: A Framework for Studying CNS Infection by Neurotropic Viruses and Screening Antiviral Drugs.
    Welsch JC; Lionnet C; Terzian C; Horvat B; Gerlier D; Mathieu C
    Bio Protoc; 2017 Nov; 7(22):e2605. PubMed ID: 34595280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.
    Colpitts CC; Baumert TF
    Hepatol Int; 2016 Sep; 10(5):741-8. PubMed ID: 27048616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted protein degradation as an antiviral approach.
    Chakravarty A; Yang PL
    Antiviral Res; 2023 Feb; 210():105480. PubMed ID: 36567024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus.
    Haga H; Sato H; Koseki A; Saito T; Okumoto K; Hoshikawa K; Katsumi T; Mizuno K; Nishina T; Ueno Y
    PLoS One; 2020; 15(11):e0242028. PubMed ID: 33152046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct-Acting Antiviral Agents for Hepatitis C Virus Infection-From Drug Discovery to Successful Implementation in Clinical Practice.
    Dietz C; Maasoumy B
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals.
    Ahmed A; Felmlee DJ
    Viruses; 2015 Dec; 7(12):6716-29. PubMed ID: 26694454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mismatched double-stranded RNA: polyI:polyC12U.
    Adis Editorial
    Drugs R D; 2004; 5(5):297-304. PubMed ID: 15357629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of nuclear receptor RORγ isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels.
    Wangen C; Raithel A; Tillmanns J; Gege C; Herrmann A; Vitt D; Kohlhof H; Marschall M; Hahn F
    Antiviral Res; 2024 Jan; 221():105769. PubMed ID: 38056603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norovirus antivirals: Where are we now?
    Netzler NE; Enosi Tuipulotu D; White PA
    Med Res Rev; 2019 May; 39(3):860-886. PubMed ID: 30584800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C.
    Falcão F; Lopes C; Viegas E; Perez R; Aldir I; Farinha H; Carvalho A; Mirco A; Marques S; Bana E Costa T; Miranda AC; Lebre L; Peixe P; Chagas C; Mansinho K; Correia JM
    Acta Med Port; 2019 Mar; 32(3):189-194. PubMed ID: 30946789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Norovirus Efficiently Replicates in Differentiated 3D-Human Intestinal Enteroids.
    Mirabelli C; Santos-Ferreira N; Gillilland MG; Cieza RJ; Colacino JA; Sexton JZ; Neyts J; Taube S; Rocha-Pereira J; Wobus CE
    J Virol; 2022 Nov; 96(22):e0085522. PubMed ID: 36342297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Changes In Cells Imaged by Soft X-ray Cryo-Tomography During Hepatitis C Virus Infection.
    Pérez-Berná AJ; Rodríguez MJ; Chichón FJ; Friesland MF; Sorrentino A; Carrascosa JL; Pereiro E; Gastaminza P
    ACS Nano; 2016 Jul; 10(7):6597-611. PubMed ID: 27328170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organotypic culture of post-mortem adult human brain explants exhibits synaptic plasticity.
    Iwasaki Y; Bernou C; Gorda B; Colomb S; Ganesh G; Gaudin R
    Brain Stimul; 2024; 17(5):1018-1023. PubMed ID: 39214185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning for mathematical models of HCV kinetics during antiviral therapy.
    Churkin A; Kriss S; Uziel A; Goyal A; Zakh R; Cotler SJ; Etzion O; Shlomai A; Rotstein HG; Dahari H; Barash D
    Math Biosci; 2022 Jan; 343():108756. PubMed ID: 34883104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased peripheral CD4
    Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
    J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antivirals against tick-borne encephalitis virus in organotypic brain slices of rat cerebellum.
    Lenz N; Engler O; Grandgirard D; Leib SL; Ackermann-Gäumann R
    PLoS One; 2018; 13(10):e0205294. PubMed ID: 30300398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection.
    Zeisel MB; Crouchet E; Baumert TF; Schuster C
    Viruses; 2015 Nov; 7(11):5659-85. PubMed ID: 26540069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.